Dispatch
Insilico credited its AI with discovering a drug, then listed five humans on the patent
MIT Technology Review dug into the gap between Insilico Medicine's press release, which said its generative platform 'discovered' a pulmonary fibrosis molecule, and the patent filing, which names five human inventors including CEO Alex Zhavoronkov with no mention of the AI. US law only allows human inventors, so companies face a choice between marketing the AI's role and filing a patent that survives challenge. Listing the wrong inventors is itself grounds for a patent challenge, which makes the marketing language a legal liability.
↳ Follow the thread